Adams Chetwood Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$464K Sell
1,919
-123
-6% -$28.3K 0.26% 58
2021
Q4
$459K Buy
2,042
+11
+0.5% +$2.32K 0.31% 54
2021
Q3
$432K Hold
2,031
0.31% 57
2021
Q2
$495K Buy
2,031
+1
+0% +$246 0.35% 55
2021
Q1
$505K Buy
2,030
+2
+0.1% +$477 0.38% 51
2020
Q4
$466K Buy
2,028
+276
+16% +$63.6K 0.39% 51
2020
Q3
$445K Buy
1,752
+1
+0.1% +$248 0.43% 47
2020
Q2
$413K Buy
1,751
+1
+0.1% +$228 0.42% 48
2020
Q1
$411K Buy
1,750
+2
+0.1% +$437 0.48% 44
2019
Q4
$421K Buy
+1,748
New +$385K 0.43% 45

Other funds holding AMGN

Adams Chetwood Wealth Management's AMGN Position: Q1 2022 in Review

Adams Chetwood Wealth Management reduced its Amgen (AMGN) stake by 6% in Q1 2022, selling an estimated $28.3K and leaving 1,919 shares worth $464K. The position accounts for 0.26% of the portfolio, ranked #58.

Adams Chetwood Wealth Management first reported a position in AMGN in Q4 2019 and has held it in 10 quarters since. The position peaked at $505K in Q1 2021. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Adams Chetwood Wealth Management held 1,919 shares of Amgen worth $464K as of Q1 2022.
  • Adams Chetwood Wealth Management sold 123 Amgen shares in Q1 2022, an estimated $28.3K.
  • Amgen made up 0.26% of Adams Chetwood Wealth Management's portfolio in Q1 2022, its #58 holding.
  • Adams Chetwood Wealth Management first reported a position in Amgen in Q4 2019 and has held it in 10 quarters since.
  • Adams Chetwood Wealth Management's Amgen position peaked at $505K in Q1 2021.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Adams Chetwood Wealth Management's 13F filing for Q1 2022, filed 13 Apr 2022.